Thirty-day Clinical Outcomes of Carotid Artery Stenting Patients with Symptomatic and Asymptomatic Carotid Artery Stenosis: Clinical Research.
- Author:
Dong Yeon SUNG
1
;
Jang Seon YOU
;
Yu Sam WON
;
Young Joon KWON
;
Jea Young YANG
;
Chun Sik CHOI
;
Yong Bum KIM
;
Byung Moon KIM
Author Information
1. Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Carotid artery;
Stent;
Angioplasty;
Carotid endarterectomy
- MeSH:
Angioplasty;
Carotid Arteries*;
Carotid Artery Diseases;
Carotid Stenosis*;
Endarterectomy, Carotid;
Humans;
Mortality;
Stents*;
Stroke
- From:Korean Journal of Cerebrovascular Surgery
2007;9(4):271-276
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Recently, carotid artery stenting (CAS) has become as the first choice of treatment for carotid artery stenosis. Although there are many differences in the outcomes of patients receiving stents among many different study groups, some reports suggest that stenting can be performed with periprocedural complication rates similar to those of a carotid endarterectomy (CEA). In this study, we investigated 39 cases of CAS. METHODS: From May 2003 to March 2007, 39 patients undergoing CAS were reviewed. We analyzed the 30-day morbidity/mortality rate. A minor stroke was defined as a new neurological deficit that either resolved completely within 30 days or increased the NIH Stroke Scale by< or =3. A major stroke was defined as a new neurological deficit that persisted for 30 days and increased the NIH Stroke Scale by> or =4. RESULTS: Among 39 patients, a minor stroke was noted in three patients (7.7%), and there were no major strokes and deaths. The overall 30-day stroke and death rate was 7.7% (n = 3). CONCLUSION: With the evolution and maturation of equipment and technique, carotid angioplasty and stenting (CAS) is increasingly being used for the treatment of carotid artery disease.
